•
PR
PRME
Prime Medicine, Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
723.85M
Volume
2.94M
52W High
$6.94
52W Low
$1.11
Open
$0.00
Prev Close
$3.89
Day Range
0.00 - 0.00
About Prime Medicine, Inc. Common Stock
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Latest News
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
Benzinga•Jan 2
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
GlobeNewswire Inc.•Dec 7
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire Inc.•Nov 7
PRME Revenue Misses by 73%
The Motley Fool•Aug 7
Prime Medicine Announces Pricing of Public Offering
GlobeNewswire Inc.•Jul 31
Why Prime Medicine Stock Is Soaring Today
The Motley Fool•Mar 19
Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire Inc.•Mar 18
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire Inc.•Nov 12